We have reported previously the enhancement of the infectivity of human immunodeficiency virus type 1 (HIV-1) by liposomes composed of the cationic lipid N-[2, 3-(dioleyloxy) propyl]-N, N, N-trimethylammonium chloride (DOTMA). To determine the mechanism by which this process occurs, we have investigated the role of CD4, serum concentration and liposome-cell interactions in the DOTMA-mediated stimulation of HIV-1 infection of A3.01 cells. Serum alone significantly inhibited the binding and infectivity of HIV-1, but DOTMA-mediated enhancement of infectivity was more pronounced in the presence of serum than in its absence. HIV-1 binding to cells was increased in the presence of DOTMA liposomes, DEAE-dextran and polybrene, all of which also enhanced infectivity to a similar extent at comparable concentrations. Fluorescence dequenching measurements indicated that DOTMA liposomes fused with HIV-1, but not with cell membranes, in the presence of serum. The enhancing effect of DOTMA liposomes on HIV-1 infectivity was CD4-dependent, and appeared to involve virus-liposome fusion and liposome binding to the cell surface. DOTMA liposomes did not mediate infection of the CD4− K562 and Raji cell lines.
AloiaR. C.,
JensenF. C.,
CurtainC. C.,
MobleyO. W.,
GordonL. M.1988; Lipid composition and fluidity of the human immunodeficiency virus. Proceedings of the National Academy of Sciences, U.S.A. 85:900–904
BanghamA. D.,
StandishM. M.,
WatkinsJ. C.1965; Diffusion of univalent ions across lamellae of swollen phospholipids. Journal of Molecular Biology 13:238–252
BussoM. E.,
ResnickL.1990; Anti-human immunodeficiency virus effects of dextran sulfate are strain dependent and synergistic or antagonistic when dextran sulfate is given in combination with dideoxynucleosides. Antimicrobial Agents and Chemotherapy 34:1991–1995
ByrnR. A.,
SekigavaI.,
ChamowS. M.,
JohnsonJ. S.,
GregoryT. J.,
CaponD. J.,
GroopmanJ. E.1989; Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4. Journal of Virology 63:4370–4375
CaoY.,
Friedman-KienA. E.,
HuangY.,
LiX. L.,
MirabileM.,
MoudgilT.,
Zucker-FranklinD.,
HoD. D.1990; CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro. Journal of Virology 64:2553–2559
Centers for Disease Control1988; 1988 Agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus. Morbidity and Mortality Weekly Report 37:Supplement S-4 1–17
Cheng-MayerC.,
RutkaJ. T.,
RosenblumM. L.,
McHughT.,
StitesD. P.,
LevyJ. A.1987; Human immunodeficiency virus can productively infect cultured human glial cells. Proceedings of the National Academy of Sciences, U.S.A. 84:3526–3530
ChesebroB.,
WehrlyK.1988; Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. Journal of Virology 62:3779–3788
ChesebroB.,
BullerR.,
PortisJ.,
WehrlyK.1990; Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells. Journal of Virology 64:215–221
ClaphamP. R.,
WeberJ. N.,
WhitbyD.,
McIntoshK.,
DalgleishA. G.,
MaddonP. J.,
DeenK. C.,
SweetR. W.,
WeissR. A.1989; Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature, London 337:368–370
DalgleishA. G.,
BeverleyP. C. L.,
ClaphamP. R.,
CrawfordD. H.,
GreavesM. F.,
WeissR. A.1984; The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature, London 312:763–767
DebsR. J.,
FreedmanL. P.,
EdmundsS.,
GaenslerK. L.,
DüzgüneșN.,
YamamotoK. R.1990; Regulation of gene expression in vivo by liposome-mediated delivery of a purified transcription factor. Journal of Biological Chemistry 265:10189–10192
DewhurstS.,
SakaiK.,
BresserJ.,
StevensonM.,
Evinger-HodgesM. J.,
VolskyD. J.1987; Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV. Journal of Virology 61:3774–3782
DüzgüneșN.,
GoldsteinJ. A.,
FriendD. S.,
FelgnerP. L.1989; Fusion of liposomes containing a novel cationic lipid, V-[2, 3-(dioleyloxy)propyl]-.N, N, N-trimethylammonium: induction by multivalent anions and asymmetric fusion with acidic phospholipid vesicles. Biochemistry 28:9179–9184
EzekowitzA. B.,
KuhlmanM.,
GroopmanJ. E.,
ByrnR. A.1989; A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. Journal of Experimental Medicine 169:185–196
FelgnerP. L.,
GadekT. R.,
HolmM.,
RomanR.,
ChanH. W.,
WenzM.,
NorthropJ. P.,
RingoldG. M.,
DanielsenM.1987; Lipofectin: a highly efficient, lipid-mediated DNA-transfection procedure. Proceedings of the National Academy of Sciences, U.S.A. 84:7413–7417
FenouilletE.,
GluckmanJ. C.,
BahraouiE.1990; Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1. Journal of Virology 64:2841–2848
FolksT. M.,
PowellD.,
LightfooteM.,
KoenigS.,
FauciA. S.,
BennS.,
RabsonA.,
DaughertyD.,
GendelmanH. E.,
HogganM. D.,
VenkatesanS.,
MartinM. A.1986; Biological and biochemical characterization of a cloned Leu-3− cell surviving infection with the acquired immune deficiency syndrome retrovirus. Journal of Experimental Medicine 164:280–290
GartnerS.,
MarkovitzP.,
MarkovitzD. M.,
KaplanM. H.,
GalloR. C.,
PopovicM.1986; The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215–219
GilbertM.,
KiriharaJ.,
MillsJ.1991; Enzyme-linked immunoassay for human immunodeficiency virus type 1 envelope glycoprotein 120. Journal of Clinical Microbiology 29:142–147
HarouseJ. M.,
KunschC.,
HartleH. T.,
LaughlinM. A.,
HoxieJ. A.,
WigdahlB.,
Gonzales-ScaranoF.1989; CD4-independent infection of human neural cells by human immunodeficiency virus type 1. Journal of Virology 63:2527–2533
HoD. D.,
RotaT. R.,
HirschM. S.1986; Infection of monocyte/macrophages by human T lymphotropic virus type III. Journal of Clinical Investigation 77:1712–1715
HoekstraD.,
de BoerT.,
KlappeK.,
WilschutJ.1984; Fluorescence method for measuring the kinetics of fusion between biological membranes. Biochemistry 23:5675–5681
HoffmanA. D.,
BanapourB.,
LevyJ. A.1985; Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:326–335
HopeM. J.,
BallyM. B.,
WebbG.,
CullisP. R.1985; Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochimica et biophysica acta 812:55–65
IkeuchiK.,
KimS.,
ByrnR. A.,
GoldringS. R.,
GroopmanJ. E.1990; Infection of nonlymphoid cells by human immunodeficiency virus type 1 or type 2. Journal of Virology 64:4226–4231
InnesC. L.,
SmithP. B.,
LangenbachR.,
TindallK. R.,
BooneL. R.1990; Cationic liposomes (lipofectin) mediate retroviral infection in the absence of specific receptors. Journal of Virology 64:957–961
KlatzmannD.,
ChampagneE.,
ChamaretS.,
GruestJ.,
GuetardD.,
HercendT.,
GluckmanJ.-C.,
MontagnierL.1984; T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature, London 312:767–768
KonopkaK.,
DavisB. R.,
LarsenC. E.,
AlfordD. R.,
DebsR. J.,
DüzgüneșN.1990; Liposomes modulate human immunodeficiency virus infectivity. Journal of General Virology 71:2899–2907
KonopkaK.,
DavisB. R.,
DüzgüneșN.1991; HIV-1 infection of a non-CD4-expressing variant of HUT-78 cells: lack of inhibition by Leu3a antibodies and enhancement by cationic DOTMA liposomes. In Mechanisms and Specificity of HIV Entry into Host Cells Edited by
DüzgüneșN.
New York: Plenum Press; (in press)
KowalskiM.,
PotzJ.,
BasiripourL.,
DorfmanT.,
GohW. C.,
TerwilligerE.,
DaytonA.,
RosenC.,
HaseltineW.,
SodroskiJ.1987; Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351–1355
KowalskiM.,
BergeronL.,
DorfmanT.,
HaseltineW.,
SodroskiJ.1991; Attentuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein. Journal of Virology 65:281–291
LarkinM.,
ChildsR. A.,
MatthewsT. J.,
ThielS.,
MizuochiT.,
LawsonA. M.,
SavillJ. S.,
HaslettC.,
DiazR.,
FeiziT.1989; Oligosaccharide-mediated interactions of the envelope glycoprotein gp120 of HIV-1 that are independent of CD4 recognition. AIDS 3:793–798
LarsenC. E.,
AlfordD. R.,
YoungL. J. T.,
McGrawT. P.,
DüzgüneșN.1990; Fusion of simian immunodeficiency virus with liposomes and erythrocyte ghosts: effect of liposome composition, pH and calcium. Journal of General Virology 71:1947–1955
LaskyL. A.,
NakamuraG.,
SmithD. H.,
FennieC.,
ShimasakiC.,
PatzerE.,
BermanP.,
GregoryT.,
CaponD. J.1987; Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50:975–985
LiX. L.,
MoudgilT.,
VintersH. V.,
HoD. D.1990; CD4-independent productive infection of a neuronal cell line by human immunodeficiency virus type 1. Journal of Virology 64:1383–1387
LifsonJ. D.1991; Fusion of HIV-infected cells with uninfected cells; CD4-dependent HIV-induced cell fusion. In Membrane Fusion Techniques, Method in Enzymology Edited by
DüzgüneșN.
New York: Academic Press; (in press)
LifsonJ. D.,
FeinbergM. B.,
ReyesG. R.,
RabinL.,
BanapourB.,
ChakrabartiS.,
MossB.,
Wong-StaalF.,
SteimerK. S.,
EnglemanE. G.1986a; Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature, London 323:725–728
LifsonJ.,
CoutreS.,
HuangE.,
EnglemanE.1986b; Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion. Journal of Experimental Medicine 64:2101–2120
LongeP.,
CabiauxV.,
LongL.,
RuysschaertJ. M.1986; Fusion of Newcastle disease virus with liposomes: role of the lipid composition of liposomes. Biochimica et biophysica acta 858:312–316
LoyterA.,
CitovskyV.,
BlumenthalR.1988; The use of fluorescence dequenching measurements to follow viral membrane fusion events. Methods of Biochemical Analysis 33:129–164
McDougalS. J.,
NicholsonJ. K. A.,
CrossG. D.,
CortS. P.,
KennedyM. S.,
MawleA. C.1986; Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. Journal of Immunology 137:2937–2944
MaddonP. J.,
DalgleishA. G.,
McDougalJ. S.,
ClaphamP. R.,
WeissR. A.,
AxelR.1986; The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333–348
MaloneR. W.,
FelgnerP. L.,
VermaI. M.1989; Cationic liposome-mediated RNA transfection. Proceedings of the National Academy of Sciences, U.S.A. 86:6077–6081
NicholsonJ. K. A.,
CrossG. D.,
CallawayC. S.,
McDougalJ. S.1986; In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). Journal of Immunology 137:323–329
OuC. Y.,
KwokS.,
MitchellS. W.,
MackD. H.,
SninskyJ. J.,
KrebsJ. W.,
FeorinoP.,
WarfieldD.,
SchochetmanG.1988; DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 239:295–297
PattersonS.,
KnightS.1987; Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus. Journal of General Virology 68:1177–1181
PincusS. H.,
WehrlyK.,
ChesebroB.1991; Use of a focal infectivity assay for testing susceptibility of HIV to antiviral agents. Bio/Techniques 10:336–342
RobinsonE. R.Jr,
MontefioriD. C.,
MitchellW. M.1987; Evidence that mannosyl residues are involved in human immunodeficiency virus type (HIV-1) pathogenesis. AIDS Research and Human Retroviruses 3:265–281
SmithD. H.,
ByrnR. A.,
MarstersS. A.,
GregoryT.,
GroopmanJ. E.,
CaponD. J.1987; Blocking of HIV-1 infectivity by a soluble secreted form of the CD4 antigen. Science 238:1704–1707
SodroskiJ.,
GohW. C.,
RosenC.,
CampbellK.,
HaseltineW.1986; Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature, London 322:470–474
SzokaF.,
OlsonF.,
HeathT.,
VailW.,
MayhewE.,
PapahadjopoulosD.1980; Preparation of unilamellar liposomes of intermediate size (0.1–0.2 µm) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochimica et biophysica acta 601:559–571
TatenoM.,
Gonzales-ScaranoF.,
LevyJ. A.1989; Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. Proceedings of the National Academy of Sciences, U.S.A. 86:4287–4290
WeberJ.,
ClaphamP.,
McKeatingJ.,
StrattonM.,
RobeyE.,
WeissR.1989; Infection of brain cells by diverse human immunodeficiency virus isolates: role of CD4 as receptor. Journal of General Virology 70:2653–2660
ZaiaJ. A.,
RossiJ. J.,
MurakawaG. J.,
SpalloneP. A.,
StephensD. A.,
KaplanB. E.,
EritjaR.,
WallaceR. B.,
CantinE. M.1988; Inhibition of human immunodeficiency virus by using an oligonucleoside methylphosphonate targeted to the tat-3 gene. Journal of Virology 62:3914–3917